These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 31378329)

  • 61. Contemporary approach to electrical and pharmacological cardioversion of atrial fibrillation.
    Rajagopalan B; Curtis AB
    Postgrad Med; 2012 Nov; 124(6):26-35. PubMed ID: 23322136
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pathway for the Management of Atrial Fibrillation and Atrial Flutter.
    Herzog E; Argulian E; Levy SB; Aziz EF
    Crit Pathw Cardiol; 2017 Jun; 16(2):47-52. PubMed ID: 28509703
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Atrial fibrillation: maintenance of sinus rhythm versus rate control.
    Sopher SM; Camm AJ
    Am J Cardiol; 1996 Jan; 77(3):24A-37A. PubMed ID: 8607388
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Atrial fibrillation in heart failure: prognostic significance and management.
    Naccarelli GV; Hynes BJ; Wolbrette DL; Bhatta L; Khan M; Samii S; Luck JC
    J Cardiovasc Electrophysiol; 2003 Dec; 14(12 Suppl):S281-6. PubMed ID: 15005215
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Maintaining stability of sinus rhythm in atrial fibrillation: antiarrhythmic drugs versus ablation.
    Naccarelli GV; Hynes J; Wolbrette DL; Bhatta L; Khan M; Luck J
    Curr Cardiol Rep; 2002 Sep; 4(5):418-25. PubMed ID: 12169239
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effectiveness of catheter ablation versus antiarrhythmic drug therapy for atrial fibrillation.
    Novak PG
    Curr Opin Cardiol; 2009 Jan; 24(1):9-17. PubMed ID: 19077814
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Management of atrial fibrillation--Part 1.
    Aronow WS
    Compr Ther; 2008; 34(3-4):126-33. PubMed ID: 19137753
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Rate or rhythm control for atrial fibrillation: update and controversies.
    Chinitz JS; Halperin JL; Reddy VY; Fuster V
    Am J Med; 2012 Nov; 125(11):1049-56. PubMed ID: 22939360
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Antiarrhythmic agents for atrial fibrillation: focus on prolonging atrial repolarization.
    Singh BN; Mody FV; Lopez B; Sarma JS
    Am J Cardiol; 1999 Nov; 84(9A):161R-173R. PubMed ID: 10568677
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Risks and benefits of rate control versus maintenance of sinus rhythm.
    Saxonhouse SJ; Curtis AB
    Am J Cardiol; 2003 Mar; 91(6A):27D-32D. PubMed ID: 12670639
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Recurrence of arrhythmia following short-term oral AMIOdarone after CATheter ablation for atrial fibrillation: a double-blind, randomized, placebo-controlled study (AMIO-CAT trial).
    Darkner S; Chen X; Hansen J; Pehrson S; Johannessen A; Nielsen JB; Svendsen JH
    Eur Heart J; 2014 Dec; 35(47):3356-64. PubMed ID: 25182250
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Review of contemporary antiarrhythmic drug therapy for maintenance of sinus rhythm in atrial fibrillation.
    Singla S; Karam P; Deshmukh AJ; Mehta J; Paydak H
    J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):12-20. PubMed ID: 21335483
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Catheter ablation versus medical therapy for patients with persistent atrial fibrillation: a systematic review and meta-analysis of evidence from randomized controlled trials.
    Chen C; Zhou X; Zhu M; Chen S; Chen J; Cai H; Dai J; Xu X; Mao W
    J Interv Card Electrophysiol; 2018 Jun; 52(1):9-18. PubMed ID: 29549512
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Amiodarone after surgical ablation for atrial fibrillation: Is it really necessary? A prospective randomized controlled trial.
    Ad N; Holmes SD; Shuman DJ; Pritchard G; Miller CE
    J Thorac Cardiovasc Surg; 2016 Mar; 151(3):798-803. PubMed ID: 26253874
    [TBL] [Abstract][Full Text] [Related]  

  • 75. In the wake of the AFFIRM trial: what we still don't know about the management of atrial fibrillation and where we need to go.
    Wyse DG
    Card Electrophysiol Rev; 2003 Jun; 7(2):130-5. PubMed ID: 14618036
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Twelve-year follow-up of catheter ablation for atrial fibrillation: A prospective, multicenter, randomized study.
    Bertaglia E; Senatore G; De Michieli L; De Simone A; Amellone C; Ferretto S; La Rocca V; Giuggia M; Corrado D; Zoppo F; Stabile G
    Heart Rhythm; 2017 Apr; 14(4):486-492. PubMed ID: 27989681
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Systematic review of the management of atrial fibrillation in patients with heart failure.
    Khand AU; Rankin AC; Kaye GC; Cleland JG
    Eur Heart J; 2000 Apr; 21(8):614-32. PubMed ID: 10731399
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
    Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
    Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: catheter ablation for atrial fibrillation/atrial flutter.
    Verma A; Macle L; Cox J; Skanes AC;
    Can J Cardiol; 2011; 27(1):60-6. PubMed ID: 21329863
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Management of atrial fibrillation in the elderly.
    Aronow WS
    Minerva Med; 2009 Feb; 100(1):3-24. PubMed ID: 19182738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.